{"id":"27f268879b6f","type":"article","url":"https://hartvaat.nl/2026/02/23/immunoadsorptie-bij-gedilateerde-cardiomyopathie-de-iaso-dcm-trial/","title":"Immunoadsorptie bij gedilateerde cardiomyopathie: de IASO-DCM-trial","title_en":"Immunoadsorption in dilated cardiomyopathy: the IASO-DCM trial.","category":"hartfalen","category_label":"Hartfalen","professions":["cardioloog"],"tags":["acuut-hartfalen","aperitif-trial","aritmogene-cardiomyopathie","cardiomyopathie-gerichte-therapie","dapa-hf","gedilateerde-cardiomyopathie","harttransplantatie","hypertrofische-cardiomyopathie","iaso-dcm","immunoadsorptie","inflammatoire-cardiomyopathie","laminopathie"],"journal":"European heart journal","doi":"10.1093/eurheartj/ehaf1055","source_url":"https://doi.org/10.1093/eurheartj/ehaf1055","authors":["Stephan B Felix","Michael Böhm","Rüdiger C Braun-Dullaeus","Alida L P Caforio","Erland Erdmann","Ulrich Grabmaier","Stefan Groß","Karin Klingel","Fabian Knebel","Kristin Lehnert","Amir A Mahabadi","Veselin Mitrovic","Matthias Nauck","Georg Nickening","Michel Noutsias","Anja Sandek","Heinz-Peter Schultheiss","Christian Schulze","Heribert Schunkert","Petar M Seferovic","Karl Stangl","Alexander Staudt","Carsten Tschöpe","Rolf Wachter","Danilo Wegner","Karl Werdan","Finn Waagstein","Åke Hjalmarson","Marcus Dörr"],"significance":8,"published":"2026-02-23","source_date":"2026-02-23","image":"","kennis":["https://hartvaat.nl/kennis/hartfalen/esc-richtlijn-hartfalen-2021/","https://hartvaat.nl/kennis/hartfalen/dilaterende-cardiomyopathie/"],"congress":"","summary_en":"The IASO-DCM trial investigated immunoadsorption as a treatment for dilated cardiomyopathy with cardiac autoantibodies, exploring a novel immunomodulatory approach to this form of heart failure.","created":"2026-07-03T10:25:49Z","updated":"2026-07-03T13:25:12Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"De IASO-DCM-trial onderzocht immunoadsorptie als behandeling voor gedilateerde cardiomyopathie met cardiale auto-antilichamen. Deze nieuwe benadering richt zich op het verwijderen van schadelijke antilichamen uit het bloed en kan een aanvulling vormen op de standaardtherapie bij geselecteerde hartfalenpatiënten.","abstract_original":""}